Current Events

Conference Series llc Ltd takes immense pleasure & feels honoured in inviting the contributors across the globe to attend “17th International Pharmaceutical Microbiology and Biotechnology Conference” to be held during April 29-30, 2019 at London, UK on the theme " explore the development of research in the field of microbiology " which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. << less

Conference Series llc Ltd takes immense pleasure & feels honoured in inviting the contributors across the globe to attend “17th International Pharmaceutical Microbiology and Biotechnology Conference” to be held during April 29-30, 2019 at London, UK on the theme " explore the development of research more >>

The BSIR IOUK is a 2 day course aimed at anyone with an interest in Interventional Radiology and Interventional Oncology. The meeting consists of a series of state of the art lectures, practical hands-on workshops and scientific sessions. The IOUK faculty is a team of key Interventional Radiology and Oncology experts.

-

The third ELRIG meeting on Advances in Cell Based Profiling in Drug Discovery will be held on the 22nd and 23rd of May 2019 at the AstraZeneca R&D premises in Gothenburg. This interactive 2-day event will host leading scientists from academia and industry to discuss current and future formats for cell based assays. This time the bi-annual meeting will be accompanied by a satellite meeting on Chemical Biology on May 24th, organized by key academic infrastructures in the Nordic countries. Our aim is to create an open and inspiring environment for networking between biologists and chemists, working towards a common view on expectations from our cell assays and their use for target identification, target validation and compound profiling purposes. << less

The third ELRIG meeting on Advances in Cell Based Profiling in Drug Discovery will be held on the 22nd and 23rd of May 2019 at the AstraZeneca R&D premises in Gothenburg. This interactive 2-day event will host leading scientists from academia and industry to discuss current and future formats for cell more >>

10th Annual Clinical Trials Summit 2019
28th May 2019, Kohinoor Continental Hotel, Mumbai, India

10th Annual Clinical Trials Summit 2019 is inspiring keynote presentations, plenary talks and panel discussions. This will discuss most recent techniques, developments, novel strategies and various disciplines involved in drug discovery, clinical research, patient centricity, clinical site & supply management, medical imaging, data management and outsourcing in clinical trials. It will educate healthcare and clinical researcher professionals about design, operation, organizing, research computing, regulatory aspects and reporting of clinical trials.

KEY SPEAKERS:
• K. BANGARURAJAN, Joint Drugs Controller (INDIA), CDSCO (HQ)
• RAVI SEKHAR KASIBHATTA, Senior Vice President, Clinical Research, Lupin
• KAMLESH PATEL, Vice President Medical Affairs, Cadilla Pharma
• ARUN BHATT, Consultant – Clinical Research & Development
• YASMIN SHENOY, Director-Regulatory Affairs, Sanofi-aventis
• LALIT LAKHWANI, Associate Director and Head of Clinical strategy, Dr. Reddy's Laboratories
• AMMAR RAZA, Country Medical Director & Chief Medical Office, Allergan
• AGAM SHAH, Head Clinical Operations, Wockhardt
• AMEY MANE, General Manager- Medical Affairs, Janssen India (Pharmaceutical companies of Johnson & Johnson)
• PRAVIN GHADGE, Head of Clinical Research Services, Reliance Life Sciences
• PRANJAL BORDOLOI, AVP - Medical Affairs and Pharmacovigilance, Veeda Clinical Research
• ASHWANI PANDITA, General Manager Quality Management & Training, Global Clinical Research Operations, Glenmark Pharmaceuticals
• ROSHAN PAWAR, Senior Medical Advisor, Alkem Laboratories
• RANJIT BARSHIKAR, QbD / CGMP Consulting, Member Editorial Board Journal of Generic Medicines, England
• PRASHANT BODHE, Director, CliniSearch
• RENUKA NEOGI, Clinical Quality, Process and Training Ambassador, Sanofi
• SUJAY KULKARNI, Senior Manager, Clinical Research and Pharmacovigilance, Glaxo Smith Kline (GSK)
KEY THEMES DISCUSSED:-
• Accomplish effective patient recruitment and retention in clinical trials by impacting innovations & digitisation in clinical research
• Bettering the grade of the international health clinical research
• Strategies for globalization in clinical trials
• Connecting the developed and the developing nations
• Leveraging new technologies to improve clinical trials efficiency in Asia
• Transforming your trials procedure by implementing artificial intelligence
• Investigating how trial sponsors and service providers can cooperate to better carry out the trial timelines while sustaining quality
• Why pharma and biotech industries are specified for new and smarter ways to conduct clinical research
• Operative patient recruitment and retention in clinical trials
• What will persuade and impact the patient?
• Successfully operate challenges in early phase clinical development
• Overcoming the key challenges within early phase clinical trials
• Developing risk-based monitoring implementation: Deduction in technology, Role progress and Business process
• Concentrating on the lessons learned and best practices resulting from 5 years of RBM implementation
• Clinical trial – A regulated procedure and plan of action
• Data safety and efficacy of the newly developed drug. What are the mandatory for further approval of the drug to bring it into the market
• Understanding the current framework of clinical trial regulations in India
• Brief information for preparing for regulatory inspection
• Be part of a major networking opportunity
WHO SHOULD ATTEND:


CEO's, CTO's, CIO's, Presidents, Vice Presidents, Directors Heads & Managers of:

Clinical Research & Development, Clinical Research Services, Clinical Operations, Clinical Data Management, Clinical IT, Clinical Trials, Medical Affairs, Regulatory Affairs, Compliance, Quality control / Assurance/GCP, Clinical Study Design, Safety Surveillance, Subject Recruitment, E-Clinical Systems.

CONFERENCE SPONSORSHIP:

E-mail – kavitha@virtueinsight.co.in Tel: +9144 24762472

Sponsor, Exhibition Stall (Booth) and a paid Speaker Slots are also available

We also have some sponsorship opportunities available for the event, which gives you an opportunity to sponsor/speak/exhibit, and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.

CONFERENCE REGISTRATION PROCESS:

E-mail – kavitha@virtueinsight.co.in Tel: +9144 24762472
• Early Bird Discount Price (Valid Till 08th April 2019) – 1 Delegate – (INR 10,000 + GST (18%) per delegate)
• Standard Price (09th April 2019 Onwards) – 1 Delegate – (INR 15,000 + GST (18%) per delegate)
• For Bulk Booking of More Than 5 Delegates – Please email us your interests to kavitha@virtueinsight.co.in
In order to register you can simply e-mail me your invoice details in the below mentioned format;
• Name:
• Company Name & Address:
• GST Number:
• Job Position:
• Contact Number:
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

<< less

10th Annual Clinical Trials Summit 2019
28th May 2019, Kohinoor Continental Hotel, Mumbai, India

10th Annual Clinical Trials Summit 2019 is inspiring keynote presentations, plenary talks and panel discussions. This will discuss most recent techniques, developments, novel strategies and various more >>

13th Biosimilars Congregation 2019
Uniting industry leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars
11th & 12th June 2019, Pestana Chelsea Bridge Hotel, London, UK
13th Biosimilars Congregation 2019 will provide insight into the current state of play in the EU and stimulate debate, in a multi-stakeholder setting, on the vital role of biosimilar medicines in the sustainability of healthcare systems. Beyond a comprehensive outlook of key European market access policies, our speakers will outline the key recent developments in regulatory science and regulatory policy in the EU and other international jurisdictions. Special emphasis will be placed on strengthening the link between regulators and medical communities as an essential basis for greater understanding and acceptance of biosimilar medicines. This Biosimilars conference will focus on multiple aspects of Biosimilar product development to successfully deliver safe, Biosimilar products to the market place. By attending this conference, you will gain a comprehensive outlook on the key issues surrounding Biosimilars. This event will provide an important platform for Biosimilars stakeholders to discuss and share best practices in furthering Biosimilars development.
KEY SPEAKERS:
• SUE NAEYAERT, Global Head Government Affairs, Policy & Pharmaceconomics, Fresenius Kabi SwissBioSim
• SHU-YI SU, Statistical Scientist, Novartis
• IAN HENSHAW, VP, Global Head of Biosimilar Business Unit, Biogen
• MAGNUS BODIN, Director, Market Access Biosimilars, Biogen
• CHRISTIAN AGBOTON, Sr Global Brand Medical Director - Global Medical Affairs, Takeda
• JOSEPH DUNFORD, European Biosimilar Franchise Manager, Accord Healthcare
• VICTOR SASTRE, Senior MSL , Amgen Biosimilars, (Board Member MSL Society Advisory)
• FREDRIK SUNDBERG, Director Strategic Customer Relations, GE Healthcare
• HANMANT BARKATE, Vice President & Head Medical Services, (India, MEA), Glenmark (India)
• JOSEPH SALAMEH, Medical Lead, Alnylam Pharmaceuticals
• STEINAR MADSEN, Medical Director, Norwegian Medicines Agency
• LOUIS BOON, CSO, Bioceros
• LIZ POLLITT, Director, BPCRCS
• LENNEKE DE WINTER, USP Director, Bioceros
• CORNELIA ULM, VP Regulatory Affairs Biosimilars, Biotec Regulatory Consulting
• KARL DAVISON, Business Development Officer, NIHR Clinical Research Network
• JUSTIN STEBBING, Professor of Cancer Medicine and Oncology, Consultant Oncologist, Imperial College Healthcare NHS Trust
• MARIE MANLEY, Partner, Head of the UK Life Sciences Practice, Sidley Austin
• JACQUELINE MULRYNE, Counsel, Arnold & Porter LLP
KEY THEMES:
• Strategies for market access and expansion by identifying key changes and future projections
• Consequences of Brexit on Biosimilars
• Current Challenges and Opportunities for future- Strategies in developing Biosimilars
• A Clinician ́s Guide to Biosimilars in Oncology: understanding the Science of Extrapolation and Interchangeability
• Biosimilars – Pricing & Market access - Bringing it faster into market
• GMP, GCP, QC & R&D
• Current challenges and opportunities - strategies to develop Biosimilars
• Payer perspective on biológics and Biosimilars
• Biosimilar Interchangeability: The newest regulation
• Biosimilar - Physicians and Patients perspective
• CMC, Preclinical and clinical considerations for Biosimilars and Follow-on Biologics
• Impact of Technology
• Commercial landscape & market access for Biosimilars: Predicts to prepare for a suceesful tomorrow
• Hear case studies on biosimilars drug development from pre-clinical to clinical and the various testing required such as immunogenicity and bio-similarity tests
• Research-based industry Biosimilar strategies
• Considerations for the analytical similarity assessments when designing a Biosimilar development program
• Determining the right investments & potential returns from Biosimilars
• Latest developments in regulation to increase speed of entry and compliance
• Future of next generation biosimilars
• Be part of a major networking opportunity
WHO SHOULD ATTEND:-
CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, and Senior Scientists from the following roles:
Biopharmaceuticals/ Biotherapeutics, Follow on Biologics/Follow on Proteins/Biosimilars, Biologics/Biotechnology/ Biogenerics, Legal Affairs, Intellectual Property, Health Economics, Pricing and Reimbursement, Clinical Immunology, Principal Scientist, Chief Scientific Officer, Process Control and Analytical Technologies, Analytical Characterisation, Regulatory Compliance, Pharmacovigilance, Drug Safety & Risk Management, Quality Affairs/ Quality Control, New Product Development, Process Science, Portfolio Management, Research & Development, Business Development, Business Operations, Scientific Affairs, Commercial Affairs, Marketing
CONFERENCE SPONSORSHIP:
Email: kavitha@virtueinsight.co.in or Tel: +44 2036120886
Sponsor, Exhibition Stall (Booth) and a paid Speaker Slots are also available
We also have some sponsorship opportunities available for the event, which gives you an opportunity to sponsor/speak/exhibit, and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.
CONFERENCE REGISTRATION:
In order to Register please let us know your interests through Email: kavitha@virtueinsight.co.in or Tel: +44 2036120886
• Introductory Offer - 3 delegate places for the price of 2 - A huge saving of £750 - (Limited seats left)
• Super Early Discount (Valid Till 1st April 2019): (£750 + VAT per delegate)
• Early Discount (2nd April 2019 - 12th May 2019): (£950 + VAT per delegate)
• Standard Registration (13th May 2019 Onwards): (£1150 + VAT per delegate)
Get more from the event, enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
<< less

13th Biosimilars Congregation 2019
Uniting industry leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars
11th & 12th June 2019, Pestana Chelsea Bridge Hotel, London, UK
13th Biosimilars Congregation 2019 will provide insight into more >>

The aim of the meeting will be to discuss molecular and structural principles of nuclear pore organisation, together with new experimental approaches, mechanisms, and models for nuclear transport. We hope to bring together scientists interested in diverse areas of nuclear pore, transport, lamina, organisation and evolution research to stimulate communication and efficient exchange of experimental results, methodology, concepts, and hypotheses.

Meeting Background
In the past two decades, our understanding of the nuclear envelope (NE) has been radically transformed. From being viewed as a simple membrane barrier with a lamin intermediate filament lining, the NE is now known to incorporate a signaling and regulatory interface as complex and dynamic as that of the plasma membrane. On the outer face of the NE, connections to cytoskeletal filaments direct cell and nuclear migration and mechanosignal transduction, whilst connections to chromatin on its inner face direct genome regulation and stability. The importance of these various roles is highlighted by the association of NE protein mutations with human diseases ranging from muscular dystrophies to neuropathies, lipodystrophies and premature ageing syndromes.

Additionally, emerging technologies are finally enabling the tackling of longstanding questions such as the higher-order structure of the lamin polymer, nuclear membrane synthesis and dynamics, and membrane protein complexes. Many ER proteins are also now being found to contribute to NE dynamics and investigations of pathogen interactions with the NE are yielding yet further insights into this complex structure. This incredible diversity of functions and structure-function relationships underscores the pleiotropy of NE-linked diseases and in this programme we draw upon experts in biophysics, biochemistry, cell biology, microscopy, and virology to highlight the wide breadth of NE functions. By bringing together diverse groups covering a wide range of expertise, from fluorescence fluxuation microscopy to crosslinking mass spectrometry to human genetics, we expect to promote a dialogue that may better elucidate NE disease mechanisms.

Topics:
▪ New directions in nuclear envelopathies
▪ Dynamic nucleo-cytoskeletal interactions and mechanotranduction
▪ Genome regulation from the nuclear envelope
▪ New nuclear envelope signaling pathways and mechanisms
▪ Detailed structure of the lamina and membrane complexes
▪ Nuclear membrane biosynthesis and dynamics
▪ Pathogen interactions with the nuclear membrane


Attendance is through invitation.


REGISTRATION AND PAYMENT

We are arranging the meeting as an ad hoc event, and require a deposit to secure the venue and the prices we have negotiated at eight months prior to the meeting, i.e. 24th January.

Provision rates and what is included are as follows (includes sales tax):

-Single room: £580,

-Double room, single occupancy: £735,

-Double room, double occupancy (accompanying person): £785 (+£160 if joining for dinners).

Please note that the hotel could only reserve 17 single rooms at the lower rate; thus these will have to be distributed either on a first-come-first-serve basis or based on need if a financial case can be made in advance.

The package includes: Five nights accommodation, full board (minus one dinner), coffee/refreshments at breaks and access to full hotel facilities.

Accompanying person in room sharing with paying participant will be entitled to: As participant without attendance at scientific sessions or lunch.

These prices are approximate, and may go down with sponsorship, down more (Brexit) or collapse completely (Brexit).

Additional suppers, lunches and other services can be of course be purchased, as can additional nights at the hotel prior to or after the meeting. These need to be negotiated direct with the hotel, but there is a preferential rate for delegates.

The excursions and gin tasting will be on a pay as you go basis.

Payment deadline is the 31st of May << less

The aim of the meeting will be to discuss molecular and structural principles of nuclear pore organisation, together with new experimental approaches, mechanisms, and models for nuclear transport. We hope to bring together scientists interested in diverse areas of nuclear pore, transport, lamina, organisation more >>

ELRIG is pleased to invite you to the Discovery Technologies meeting.

-

BSIR ASM 2019 will take place at Manchester Central on 13th -15th November 2019. Further information : meeting.bsir.org/2019/

QR Code Badge Scanning:
To scan attendee badges click on the icon at the bottom of the App 'Scan'. Once you scan a badge you can also add notes to the scan. To view all your scan and email/download in spreadsheet format go to the icon 'Favourites'.